By Kashish Tandon, Bhanvi Satija and Rishika Sadam HYDERABAD (Reuters) - The rising adoption of artificial intelligence in ...

BioAsia 2025 in Hyderabad attracts global leaders, investments, and innovations in life sciences and pharma industry.

Amgen (NASDAQ:AMGN) shares snapped six straight sessions of gains, as the stock was down 3% at $306.2 on Wednesday. The ...

A total of 84 promising startups showcased groundbreaking innovations, offering solutions to some of the most pressing global ...

Apple shareholders on February 25 voted to keep the tech giant's diversity, equity and inclusion (DEI) policies, a win for ...

Eleven pharmaceutical companies have committed to investing Rs 5445 crore and creation of 9800 jobs in Telangana at Hyderabad ...

NEW DELHI – U.S. drugmaker Amgen plans to invest approximately $200 million this year in its new technology center located in ...

US biotech major Amgen will invest about $200 million this year in its new technology center in southern India.

Hyderabad: The 22nd edition of BioAsia 2025, Asia’s largest life sciences and healthcare conference, was inaugurated by Chief ...

US drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further ...

Amgen opens new technology and innovation site in Hyderabad, to invest $200 million through 2025: Our Bureau, Bengaluru ...